糖質吸収不全症
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Miglustat-induced intestinal carbohydrate malabsorption is due to the inhibition of α-glucosidases, but not β-galactosidases.
- Amiri M, Naim HY.SourceDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559, Hannover, Germany.
- Journal of inherited metabolic disease.J Inherit Metab Dis.2012 Nov;35(6):949-54. doi: 10.1007/s10545-012-9523-9. Epub 2012 Sep 14.
- Miglustat is an oral medication that has approved indication for type I Gaucher disease and Niemann pick disease type C. Usually treatment with Miglustat is associated with occurrence of gastrointestinal side effects similar to carbohydrate maldigestion symptoms. Here, we studied the direct influenc
- PMID 22976762
Japanese Journal
- 瓜田 純久,杉本 元信,三木 一正
- におい・かおり環境学会誌 = Journal of Japan Association on Odor Environment 37(2), 99-104, 2006-03-25
- NAID 10017973261
Related Links
- Carbohydrate malabsorption is a condition in which the body cannot break down carbohydrates properly. People with this condition... ... You won't believe these 10 facts about people 10 most extreme places on Earth Top 10 ...
- I have carbohydrate malabsorption (otherwise known as dissacharidase defficiency). Both are just fancy names for the fact that my body doesn't make enough enzymes to break down and properly absorb carbohydrates. Like ...
★リンクテーブル★
[★]
- 英
- carbohydrate malabsorption
[★]
糖質吸収不全症候群
[★]
[★]